111 related articles for article (PubMed ID: 37973486)
1. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
Gallet Q; Bouteloup V; Locatelli M; Habert MO; Chupin M; Campion JY; Michels PE; Delrieu J; Lebouvier T; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MS; Gissot V; El-Hage W; Camus V; Gohier B; Desmidt T;
Am J Geriatr Psychiatry; 2024 Jun; 32(6):665-677. PubMed ID: 37973486
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine use and neuroimaging markers of Alzheimer's disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort.
Gallet Q; Bouteloup V; Locatelli M; Habert MO; Chupin M; Delrieu J; Lebouvier T; Robert G; David R; Bulteau S; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MJ; Barantin L; Andersson F; Cottier JP; Gissot V; El-Hage W; Camus V; Gohier B; Desmidt T;
Neuropsychopharmacology; 2022 Apr; 47(5):1114-1120. PubMed ID: 34893757
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
Gardener SL; Sohrabi HR; Shen KK; Rainey-Smith SR; Weinborn M; Bates KA; Shah T; Foster JK; Lenzo N; Salvado O; Laske C; Laws SM; Taddei K; Verdile G; Martins RN
J Alzheimers Dis; 2016 Mar; 52(2):661-72. PubMed ID: 27031482
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort.
Desmidt T; Delrieu J; Lebouvier T; Robert G; David R; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MJ; Payoux P; Vellas B; El-Hage W; Tavernier E; Camus V;
Neurobiol Aging; 2019 Dec; 84():61-69. PubMed ID: 31514054
[TBL] [Abstract][Full Text] [Related]
5. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer's Disease.
Qiao Z; Wang G; Zhao X; Wang K; Fan D; Chen Q; Ai L
Front Aging Neurosci; 2022; 14():841942. PubMed ID: 35663582
[TBL] [Abstract][Full Text] [Related]
7. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F
Chung JK; Nakajima S; Shinagawa S; Plitman E; Chakravarty MM; Iwata Y; Caravaggio F; Pollock BG; Gerretsen P; Graff-Guerrero A;
Am J Geriatr Psychiatry; 2016 Nov; 24(11):1028-1039. PubMed ID: 27538351
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
[TBL] [Abstract][Full Text] [Related]
11. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
12. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
[TBL] [Abstract][Full Text] [Related]
14. The effect of β-amyloid positivity on cerebral metabolism in cognitively normal seniors.
Bozoki AC; Zdanukiewicz M; Zhu DC;
Alzheimers Dement; 2016 Dec; 12(12):1250-1258. PubMed ID: 27445158
[TBL] [Abstract][Full Text] [Related]
15. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
[TBL] [Abstract][Full Text] [Related]
16. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
17. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
18. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
[TBL] [Abstract][Full Text] [Related]
19. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
20. Generation of synthetic PET images of synaptic density and amyloid from
Wang R; Liu H; Toyonaga T; Shi L; Wu J; Onofrey JA; Tsai YJ; Naganawa M; Ma T; Liu Y; Chen MK; Mecca AP; O'Dell RS; van Dyck CH; Carson RE; Liu C
Med Phys; 2021 Sep; 48(9):5115-5129. PubMed ID: 34224153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
